Compare Bristol-Myers Squibb Co (BMY) vs Reddit Inc (RDDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Reddit Inc — how do they compare? Bristol-Myers Squibb Co trades at $57.41 (market cap $116.30B), while Reddit Inc trades at $203.89 (market cap $39.13B). The key difference: Bristol-Myers Squibb Co is far larger — about 3× Reddit Inc's market cap, and Bristol-Myers Squibb Co pays a 4.42% dividend while Reddit Inc pays none. Which is the better fit depends on your goals.
| BMY | RDDT | |
|---|---|---|
Market Cap | $116.30B | $39.13B |
Sector | Health | Media |
52-Week High | $62.37 | $270.71 |
52-Week Low | $42.60 | $121.84 |
Enterprise Value | $152.24B | $36.38B |
Dividend Yield | 4.42% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bristol Myers Squibb (BMY) trades at $59.34, up 3.06% today, with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with a 15.01% net margin and 38.84% ROE, though debt levels have risen. Recent FDA acceptance for mezigdomide in multiple myeloma highlights pipeline progress. Analysts are mixed with a $60 consensus target, slightly above current price.
BMY offers value with a P/E of 16.62 and a safe 4.3% dividend yield, but faces patent cliff risks and pricing pressures. Earnings growth and pipeline execution are key catalysts, while high debt and competitive threats require monitoring. The stock presents a balanced opportunity for income-focused investors with moderate risk tolerance.
Reddit (RDDT) trades at $200.71, up 2.71% today, with a bullish technical outlook supported by moving averages and ADX signals. The stock shows strong fundamentals with 45% revenue growth, a 28.6% net income margin, and robust cash flow. Recent news highlights AI safety initiatives and digital ad momentum, while Q2 2026 earnings are anticipated on July 30, 2026.
The investment outlook is positive, driven by earnings beats, analyst consensus of $235.25 price target, and 63% buy ratings. Risks include high valuation multiples and competitive pressures in digital advertising. Upside potential hinges on sustained user engagement and execution of growth strategies.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →
